Streetbeat News

Price Targets

PYPD

Barclays analyst Balaji Prasad has maintained an Equal-Weight rating on PolyPid (NASDAQ:PYPD) and raised the price target from $2.5 to $10.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 2:46 pm

REE

Cantor Fitzgerald analyst Andres Sheppard has maintained a Neutral rating on REE Automotive (NASDAQ:REE) and raised the price target from $1 to $4.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 2:35 pm

MRK

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK) and maintained a price target of $135.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 2:25 pm

BJRI

Barclays analyst Jeffrey Bernstein maintains an Underweight rating on BJ's Restaurants (NASDAQ:BJRI) and has lowered the price target from $31 to $23.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 2:19 pm

AMAM

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Ambrx Biopharma (NASDAQ:AMAM) and maintained a $25 price target.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 2:19 pm

JNJ

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Johnson & Johnson (NYSE:JNJ) and maintained a price target of $215.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 2:17 pm

PRTA

Cantor Fitzgerald analyst Charles Duncan has reiterated an Overweight rating on Prothena Corp (NASDAQ:PRTA) and maintained a price target of $129.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 2:15 pm

LLY

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly (NYSE:LLY) and maintained a price target of $630.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 2:13 pm

CTVA

Wells Fargo has maintained an Overweight rating on Corteva's stock but has lowered its price target from $73 to $66. This has led to a decrease in Corteva's share price.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 2:12 pm

OKTA

Okta's shares are trading lower due to a security breach in its support system, where a threat actor viewed customer files. Keybanc maintained an Overweight rating on Okta but reduced its price target from $106 to $95.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 2:11 pm